Clinical Trials Browser

Phase 1/2 × OTHER × Carcinoma, Medullary × Clear all

Sinonasal undifferentiated carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Glioblastoma, Melanoma, Testicular Neoplasms, Carcinoma, Merkel Cell, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory

NCT05278364 2023-04-12

Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor

Phase 1/2 Unknown

184 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Medullary

NCT01730638 2022-07-26

iTEP-CMT

Phase 1/2 Completed

25 enrolled

Head & Neck

Thyroid Diseases, Carcinoma, Medullary

NCT00354523 2014-12-17

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

Phase 1/2 Terminated

21 enrolled

Head & Neck

Thyroid Neoplasms, Carcinoma, Medullary

NCT00004048 2011-06-22

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer

Phase 1/2 Completed

30 enrolled

Head & Neck

Head and Neck Neoplasms, Carcinoma, Medullary

Clinical Trials

RABBIT

Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor

iTEP-CMT

Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma

Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer